John R. Murphy - Jan 19, 2023 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role: Director
Signature: /s/ John R. Murphy
Stock symbol: CVKD
Transactions as of: Jan 19, 2023
Transactions value $: $0
Form type: 3
Date filed: 1/19/2023, 07:20 PM
Previous filing: Aug 4, 2022
Next filing: Jan 24, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CVKD	Common Stock						50K	Jan 19, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CVKD	Stock Options							Jan 19, 2023	Common Stock	100K	$0.64	Direct
holding	CVKD	Convertible Promissory Note							Jan 19, 2023	Common Stock	515K	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Murphy is the holder of a convertible promissory note in the principal amount of $500,000 that is convertible into 514,792 shares of common stock issuable upon consummation of the initial public offering of Cadrenal Therapeutics, Inc., based on an as adjusted conversion price of $1.00 per share.